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Tertiary lymphoid tissues (TLTs) have been observed
in the meninges of multiple sclerosis (MS) patients,
but the stromal cells and molecular signals that sup-
port TLTs remain unclear. Here, we show that T
helper 17 (Th17) cells induced robust TLTs within
the brain meninges that were associated with local
demyelination during experimental autoimmune en-
cephalitis (EAE). Th17-cell-induced TLTs were
underpinned by a network of stromal cells producing
extracellular matrix proteins and chemokines,
enabling leukocytes to reside within, rather than sim-
ply transit through, the meninges. Within the CNS, in-
teractions between lymphotoxin ab (LTab) on Th17
cells and LTbR on meningeal radio-resistant cells
were necessary for the propagation of de novo inter-
leukin-17 responses, and activated T cells from MS
patients expressed elevated levels of LTbR ligands.
Therefore, input from both Th17 cells and the lym-
photoxin pathway induce the formation of an im-
mune-competent stromal cell niche in the meninges.
INTRODUCTION
Tertiary lymphoid tissues (TLTs) are leukocyte aggregates that
form at sites of chronic inflammation or persistent microbial
colonization (Aloisi and Pujol-Borrell, 2006). TLTs share some
structural similarities with secondary lymphoid organs (SLOs),
suggesting that TLTs might have the capacity to support priming
of immune responses at the site of inflammation where neo-self-1160 Immunity 43, 1160–1173, December 15, 2015 ª2015 Elsevier Inantigens or foreign antigens are abundant. Recent studies on
post-mortem tissue have revealed that patients with a progres-
sive form of multiple sclerosis (MS) can show evidence of
lymphocyte-rich aggregates in the brain meninges, and in
some cases, these collections of leukocytes have been shown
to be associated with cortical demyelination, axonal atrophy,
and accelerated disease progression (Magliozzi et al., 2007).
Although limitations in cortical imaging, inaccessibility of tissue
sampling, and the long clinical duration of the disease hinder
the ability to study TLT formation in the MS-affected brain,
some rodent models of MS (experimental autoimmune enceph-
alomyelitis [EAE]) recapitulate meningeal TLTs and represent our
best tool for studying TLT formation in vivo (deLuca et al., 2010;
Peters et al., 2011).
In SLOs, specialized stromal cells such as fibroblastic reticular
cells (FRCs) and follicular dendritic cells (FDCs) underpin resi-
dent lymphocytes. During embryonic development, lymphoid
tissue inducer (LTi) cells promote stromal cell chemokine secre-
tion and stromal cell maturation, and aspects of both processes
can be dependent on the lymphotoxin (LT) pathway. The LT b re-
ceptor (LTbR) is a member of the tumor necrosis factor (TNF)
superfamily and plays an important role in lymph node (LN)
organogenesis and T cell activation (Lu and Browning, 2014;
Summers deLuca and Gommerman, 2012). LTbR is expressed
on stromal cells, dendritic cells (DCs), and macrophages,
whereas its ligand LTab is expressed on embryonic LTi cells,
as well as adult hematopoietically derived cells, including innate
lymphoid cells (ILCs), B cells, natural killer cells, and activated
T cells. In addition to playing a role in LN organogenesis, the
LT pathway has also been implicated in TLT formation. Overex-
pression of LTab in the pancreas induces TLTs that contain
lymphoid-tissue-like stromal cells (Drayton et al., 2003). How-
ever, the relevant LTbR-expressing cell types that drive these
TLTs under physiological conditions are unknown. In additionc.
to the LT pathway, interleukin-17 (IL-17)-producing cells have
also been implicated in driving TLT formation in models of
chronic inflammation (Grogan and Ouyang, 2012; Peters et al.,
2011), yet a mechanism by which these cells promote ectopic
TLT formation, particularly vis-a-vis the LT pathway, remains un-
resolved. In addition, the factors that are producedwithin TLTs at
sites of inflammation and the role of TLTs in tissue-directed T cell
responses remain unclear. These questions have important rele-
vance to diseases where TLTs have been observed.
In this study, we examined the cellular andmolecular drivers of
meningeal TLT formation during EAE. We showed that T helper
17 (Th17) cells could remodel stroma derived from the brain
meninges in vitro and in vivo and thus induce the production of
extracellular matrix (ECM) proteins, chemokines, and cytokines.
This remodeled meningeal microenvironment had the potential
to support the recruitment and maintenance of inflammatory
cells in the CNS.Whereas stromal cell remodeling and ECM pro-
duction were independent of the LTbR pathway, we found that
CNS-invading IL-17-producing CD4+ T cells required communi-
cation between initiating encephalitogenic Th17 cells that ex-
pressed LTab and a radio-resistant LTbR-expressing cell type.
Moreover, we found that activatedCD4+ T cells fromMSpatients
expressed higher levels of LTbR ligands than did those of healthy
control individuals. Collectively, our results suggest that Th17
cells initiate TLT formation by remodeling meningeal-resident
stromal cells during EAE and propagate neuroinflammation by
virtue of their expression of LTab.
RESULTS
Th17 Cells Induce TLTs in the Brain Meninges
Associated with Local Demyelination
We first sought to determine the location and cellular composi-
tion of TLTs in the context of an animal model of MS. It has
been shown that MOG peptide-driven C57Bl/6 models of EAE
exhibit inflammation primarily in the spinal cord (Kuerten et al.,
2011). To examine these questions in the context of the brain
meninges, the location where B-cell-rich follicles have been
described in progressive MS, we used the SJL/J EAE model
(deLuca et al., 2010). Throughout the remitting-relapsing disease
course of EAE in SJL/J mice, we observed immune cell infiltrates
of varying magnitude in the leptomeninges of the hippocampal,
cerebellar, and brainstem fissures, and they extended to the
tela choroidea of the ventricles (Figure S1A), as well as over
the dorsal and ventral brainstem (data not shown). In some
areas, the infiltrates extended into the adjacent parenchyma
(Figure S1A, bottom left), often around penetrating blood ves-
sels. In some animals, more diffuse and less intense collections
of inflammatory cells were scattered throughout other areas of
the meninges. At clinical onset of disease, T lymphocytes domi-
nated meningeal TLTs, whereas at the peak of the acute phase
and in relapsing mice, mixed B and T cell meningeal aggregates
were observed (Figure S1B; representative clinical course is de-
picted in Figure S1C). In summary, T cells initially populated
meningeal TLTs, and then an influx of other cell types, including
B cells, followed.
Given the importance of Th17 cells in promoting TLTs (Peters
et al., 2011), we next established a Th17-cell-driven model of
EAE by adoptive transfer (A/T) of CD45.2+ Th17 cells derivedImmfrom SJL/J donors immunized against myelin proteolipid protein
(PLP). In the days preceding clinical onset, transferred Th17 cells
preferentially increased in frequency in the CNS rather than in the
cervical LNs of CD45.1 congenic hosts (Figure 1A, note scale dif-
ference). Approximately 25% of adoptively transferred Th17
cells also expressed IL-17, but very few transferred Th17 cells
expressed interferon-g (IFN-g) (Figure 1B). We also noted that
adoptively transferred cytokine-producing cells in the meninges
were specific to PLP139–151 (data not shown). Compared to the
transferred CD45.2+ Th17 cells, a low frequency of endogenous
(CD45.1+) T cells expressed IL-17 or IFN-g (Figure 1B). Whereas
both transferred and endogenous cells accumulated predomi-
nantly in the meninges at clinical onset, we observed that trans-
ferred T cells stained positive for Ki-67 in meningeal-localized
leukocytes (Figure 1C). Indeed, using flow cytometry, we found
that 35.43%± 5.36% (n = 19) of adoptively transferred Th17 cells
expressed Ki-67, suggesting local proliferation of Th17 cells
(data not shown). Notably, meningeal follicle formation in the
brain was more robust when EAE was induced by A/T of Th17
cells than when it was induced by active immunization (Fig-
ure 1D). Th17-cell-induced TLTs were populated by B cell clus-
ters, whereas CD4+ T cells and CD11c+ cells were more
dispersed within the emerging TLTs (Figure 1E). In summary,
adoptively transferred encephalitogenic T cells rapidly localized
to themeninges, where they proliferated and secreted cytokines.
In order to determine whether influx of Th17 cells into the
meninges results in local pathology, we used luxol fast blue
(LFB) histochemical staining to examine the myelin in the subpial
parenchyma adjacent tomeningeal TLTs, as well as in the paren-
chyma around perivascular infiltrates, away from the meninges.
Areas adjacent to intraparenchymal perivascular infiltrates and
areas adjacent to meningeal TLTs were both proximally associ-
ated with rarified myelin and myelin debris, indicative of ongoing
demyelination. In addition, using immunohistochemistry for glial
fibrillary acidic protein (GFAP), we observed reactive gliosis in
the subpial parenchyma adjacent to the meningeal collections
of lymphocytes and an increased number of often-thickened as-
trocytic processes abutting a thickened glial limitans. In general,
these changes were similar to those seen around parenchymal
perivascular infiltrates (Figures 1F and 1G), although there was
a subtle qualitative suggestion that the changes in the latter
were more severe. Brain pathology was then graded for each in-
dividual mouse (see Supplemental Experimental Procedures).
Mice with Th17-cell-induced EAE exhibited a significant correla-
tion between the cumulative inflammation score (the sum of
criteria 1–3 in Table S1) and the cumulativemeningeal-lesion-pa-
thology score (the sum of criteria 4 and 5; r2 = 0.2644, p = 0.0347;
Table S1). In summary, beginning with the infiltration of Th17
cells, followed by B cells and other leukocytes, TLTs readily
formed in the brain meninges during SJL/J EAE, and meningeal
TLTs were associated with local demyelination and reactive glio-
sis in a mouse model of MS.
Th17 Cells Induce an FRC-like Stromal Cell Network in
the Meninges
We next examined changes in meningeal stromal cell popula-
tions during EAE. LN stroma can be classified into four popula-
tions according to the expression of podoplanin (Pdpn,
also known as gp38) and CD31: (1) FRCs (gp38+CD31), (2)unity 43, 1160–1173, December 15, 2015 ª2015 Elsevier Inc. 1161
Figure 1. Th17 Cells Locate to the Meninges and Induce TLTs Associated with Local Demyelination
(A) Flow cytometric analysis of the frequency of adoptively transferred CD45.2+ encephalitogenic Th17 cells in the cervical LNs and CNS at the indicated time
points after Th17 cell A/T. Clinical disease onset for this experiment was day 8 after transfer. Data represent two independent experiments each with four to five
mice per time point.
(B) Flow cytometric analysis of the frequency of IL-17- and IFN-g-producing CD4+ T cells in the CNS on the day of clinical onset (day 8) for both transferred
(CD45.2+) and endogenous (CD45.1+) cells. Data represent at least two individual experiments with four to seven mice per group.
(C) Corresponding representative immunofluorescence (IF) image demonstrates the accumulation of transferred CD45.2+ cells, co-stained for Ki-67, within the
brain meninges on the day of clinical onset. Data represent two independent experiments with at least four mice per experiment.
(D) Quantification of the average area of meningeal TLTs in mice during the acute phase of active EAE or Th17 cell A/T EAE. Data represent two independent
experiments with four to seven mice per group.
(E) IF imaging demonstrates the cellular composition of brain meningeal TLTs, including CD4+, B220+, and CD11c+ cells. Images represent brain tissue collected
in the acute phase of Th17 cell A/T EAE, and the cellular composition was verified in two independent experiments examining at least three mice per experiment
(2003 magnification).
(F) Histology using H&E and luxol fast blue (LFB) staining. Depicted is an area of meningeal inflammation with underlying demyelination located between the
ventro-rostral cerebellum (Cer) and the dorsal brain stem (DBS). High magnification of the boxed area shows myelin rarefaction and vacuoles (ovoids) containing
clumps of blue degraded myelin (arrows). A normally myelinated tract and a perivascular infiltrate are shown for comparison. Representative images are shown
from mice described in Table S1. Scale bars represent 2 mm, except in the top left image, where the scale bar represents 5 mm.
(G) Matching LFB and H&E sections (left) and GFAP sections (right) of a meningeal infiltrate (arrows) and underlying subpial dorsal brain stem (DBS) parenchyma.
The cerebellum (Cer) lies dorsal to the fissure. Arrows indicate a thickened glia limitans located below the meningeal infiltrate.
All histological examples depicted were derived from mice that exhibited clinical disease onset at days 5 and 6 after A/T. See also Figure S1 and Table S1.lymphatic endothelial cells (gp38+CD31+), (3) blood endothelial
cells (gp38CD31+), and (4) gp38CD31 double-negative
(DN) cells (Malhotra et al., 2012). Compared with the meninges
of naive mice, the meninges of mice with Th17 cell A/T EAE
showed a marked increase in the frequency of FRC-like gp38+
CD31 cells, as well as a contraction of the gp38CD31 DN
population (Figures 2A and 2B). Pericytes and meningeal
fibroblasts, both of which express PDGFRb, are stromal cell
populations known to reside in the non-inflamed CNS. However,
meningeal fibroblasts can be distinguished from pericytes by
their expression of PDGFRa and production of ECM (Armulik
et al., 2011). Indeed, within the gp38+CD31 population, we
observed a subset of PDGFRaPDGFRb+ cells and a second1162 Immunity 43, 1160–1173, December 15, 2015 ª2015 Elsevier Inpopulation of PDGFRa+PDGFRb+ cells, which we elected to
call ‘‘meningeal FRC-like cells.’’ These gp38+CD31 cells closely
resembled LN FRCs (Figure S2A) and were significantly
expanded in EAEmice (Figure 2C). A similar increase in the num-
ber of gp38+CD31 FRC-like cells was also observed in the
meninges of C57Bl/6 mice during EAE (Figures S2B and S2C).
Therefore, independently of the genetic background, we
observed a mixture of FRC-like fibroblasts and pericytes in the
meninges during EAE.
To visualize the organization of meningeal stromal cells in situ
during Th17 cell A/T EAE, we used immunofluorescence (IF) to
stain for PDGF receptors. Consistent with the increased fre-
quency of meningeal FRC-like cells during EAE, we observedc.
Figure 2. An FRC-like Stromal Cell Network Forms in the Meninges during Th17 Cell A/T EAE in SJL/J Mice
(A) Representative fluorescence-activated cell sorting (FACS) plots show meningeal stromal cell populations that expressed gp38 and CD31 after CD45+ cells
(left panel) were gated out. Shown are subsets of FRC-like gp38+CD31PDGFRa+b+ cells and gp38+CD31PDGFRab+ cells (right panel) in the meninges
isolated from either naive mice (top) or acute-phase Th17 cell A/T EAE mice (bottom). Data represent three independent experiments each with three to six
EAE mice.
(B and C) Flow cytometric analysis of gp38+CD31 and gp38CD31 stromal cells (B) or PDGFRa+b+gp38+CD31 stromal cells (C) from the meninges of naive
mice and mice with Th17 cell A/T EAE. Data were pooled from two experiments and represent three independent experiments each with three to six EAE mice.
(D) Representative IF imaging demonstrates a PDGFRa+/PDGFRb+ stromal cell network interwoven with a fibronectin+ and ERTR7+ ECM network in the
meninges of Th17 cell A/T EAE SJL/J mice (lower three panels). In the meninges of naive mice, fibronectin outlines the meningeal membrane, and PDGFRb+ cells
(legend continued on next page)
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an elaborate PDGFRa+PDGFRb+ cellular network that was inter-
woven with fibronectin and ER-TR7, which are well-established
FRC-associated ECM components (Malhotra et al., 2012) (Fig-
ure 2D). Within this ECM network, we also observed PDGFRb+
cells that were not immunoreactive for PDGFRa. Thismixed stro-
mal cell network displayed the adhesion molecule ICAM, which
could conceivably serve to ‘‘trap’’ infiltrating leukocytes (but
not VCAM, which was only found on vasculature) (Figure S3).
Indeed, the ECM-stromal-cell network was observed to under-
pin aggregates of CD45+ leukocytes (Figure 2D). In contrast, in
naive mice, fibronectin expression was constrained to the
meningeal membrane and the vasculature (identified by actin
staining in smooth muscle), and neither elaboration of a cellular
network nor an associated ECM network was observed (Fig-
ure 2D, top row). Therefore, in the meninges, FRC-like cells
formed a stromal cell network that was decorated with ICAM-1
and ECM components during EAE.
IL-17 and IL-22 Remodel Meningeal Fibroblasts In Vitro
and In Vivo
Next, we examined whether the induction of a meningeal FRC
network was a direct consequence of Th17 cells and/or their
by-products. We co-cultured isolated meningeal fibroblasts
with unstimulated splenocytes, Th17-skewed cells, or recombi-
nant IL-17 and IL-22. As expected, treatment with IL-17 and IL-
22 led to increased expression of the Th17 cell responsive gene
Cxcl1 (Figure S4A). We observed that co-culture of meningeal fi-
broblasts with Th17 cells, and to a greater extent conditioned
medium from Th17 cells or recombinant IL-17 and IL-22, led to
the re-distribution of actin and collagen in vitro (Figure 3A). To
quantify changes that were occurring in the meningeal fibro-
blasts upon treatment with IL-17 or IL-22, we measured tran-
script levels of ECM elements and the matrix metalloproteinase
Mmp9, which have been previously shown to be upregulated in
MS lesions (Mohan et al., 2010; van Horssen et al., 2005). We
noted that compared to untreated fibroblasts, cells treated
with IL-22, and in some cases IL-17, showed upregulation of
ECM components andMmp9 (Figure 3B). Furthermore, isolated
meningeal fibroblasts were found to express Ltbr and the consti-
tutive B cell chemokineCxcl13, although the expression of these
genes was no different in cells treated with IL-17 or IL-22 than in
untreated control cells (Figure 3C). On the other hand, no detect-
able expression of T cell chemokines Ccl19 and Ccl21 was
observed in isolated meningeal fibroblast cultures treated with
IL-17 or IL-22. Therefore, Th17 cells and their soluble mediators
directly induced morphological and gene-expression changes in
culturedmeningeal fibroblasts, implying that the accumulation of
such ECM components in the meningeal space was occurring
in situ.
Todeterminewhether IL-17and/or IL-22was required for fibro-
blast remodeling in vivo, we transferred pre-primed donor
encephalitogenic Th17 cells into recipient mice prophylactically
implanted with ALZET pumps loaded to deliver anti-IL-17, anti-surround the vascular endothelium (SMA+, denoted by asterisks, top panel). Da
periments with three to five mice per group. All images represent a similar locatio
however, the right-most column is 2003.
In all cases, center values depicted are means. **p% 0.01, ***p% 0.001 (Mann-W
days 5 and 6 after A/T. See also Figures S2 and S3.
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globulin (Ig) via the intra-cerebroventricular (i.c.v.) route. This
strategy allowed us to interrupt the activity of IL-17 and/or IL-22
in the CNS. Whereas singular treatment with either anti-IL-17 or
anti-IL-22 had no obvious effect on fibroblast remodeling (Fig-
ure S4B), simultaneous inhibition of both IL-17 and IL-22 resulted
in a significant reduction in the extent of the fibronectin network in
meningeal locations rich in leukocytes (Figures 3Dand3E). These
visual differences in fibronectin remodeling were consistent with
a reduction in the expression of Col1a, Fn1, Dcn, Icam1, and
Mmp9 transcripts in mice treated with both anti-IL-17 and anti-
IL-22 (Figure S4C). The observed reduction in the fibronectin
network in dual-treated mice correlated with a modest reduction
in clinical severity of disease (Figure 3F). Because the observed
inhibition of fibroblast remodeling in the meninges after i.c.v.
treatmentwith anti-IL-17 andanti-IL-22waspartial, this suggests
that either the concentration of anti-IL-17 and anti-IL-22 via i.c.v.
delivery was insufficient to fully affect fibroblast remodeling and
disease or, alternatively, other signals substituted for IL-17 and
IL-22 to initiate the formation of TLTs. Indeed, in head-to-head
experiments, we found that Th1 and Th17 cells had a similar ca-
pacity to initiate the early stages of TLT formation in themeninges
in SJL/J recipientmice (Figure S5). Thus, we hypothesize that by-
products produced by endogenous Th1 cells that migrate to the
CNS in SJL/J mice, such as TNF-a (which can initiate TLTs in ad-
ipose tissue [Be´ne´zech et al., 2015]), might collaborate with IL-17
and IL-22 to induce TLT formation. In summary, whereas IL-17
and IL-22 were mutually compensatory for Th17-cell-induced
fibroblast remodeling in the meninges, inhibition of both cyto-
kines reduced this process while also dampening disease
severity.
LTbR Signaling Is Dispensable for Meningeal Fibroblast
Remodeling but Supports the Accumulation of B Cells
and Deposition of Complement within TLTs
Having shown that an FRC-like stromal cell network was estab-
lished in the meninges of both SJL/J and C57Bl/6 EAE mice, we
next turned our attention to the molecular signals that drove TLT
maturation and disease progression. Inhibition of LTbR signaling
has been shown to ablate meningeal B cell accumulation during
active EAE (Columba-Cabezas et al., 2006). However, the mech-
anism for how this pathway is involved in TLT formation and/or
maintenance, particularly in the context of a Th17-cell-driven
model, has not been explored. To test how the LT pathway af-
fects TLT formation, we transferred donor encephalitogenic
Th17 cells into recipient mice prophylactically implanted with
ALZET pumps loaded to deliver LTbR-Ig or control Ig via the
i.c.v. route. Compared to control mice, mice treated with
LTbR-Ig via the i.c.v. route showed unaltered formation of a
fibronectin+PDGFRb+ meningeal FRC-like network, as well as
an EAE-induced increase in the frequency of CD45gp38+
CD31 cells in the meninges (Figures 4A–4B; Figure S6A).
Furthermore, the expression of ECM components and ICAM-1ta were derived from three unimmunized mice and two independent EAE ex-
n in the brain (along the hippocampal fissure) and are at 4003 magnification;
hitney U test). Day of clinical disease onset for this experiment was between
c.
Figure 3. Th17 Cells, IL-17, and IL-22 Remodel Meningeal Fibroblasts In Vitro and In Vivo, and CNS-Intrinsic Activity of IL-17 and IL-22
Promotes Clinical Disease
(A) Meningeal fibroblasts were co-cultured with the indicated cells or cytokines for 24 hr and then subjected to IF for visualization of actin fibers, collagens, and
nuclei.
(B and C) Expression of candidate ECM components andMmp9 (B) and Ltbr, Cxcl13, Ccl19, and Ccl21 (C) produced by meningeal fibroblasts treated with the
indicated cytokines was examined by qRT-PCR. Data were pooled from two independent experiments.
(D) Representative IF images demonstrate fibronectin (green) and PDGFRa/b (red) staining within meningeal TLTs of mice treated with the denoted pharma-
cological reagent via the i.c.v. route. The right column depicts CD45+ (blue) leukocytes in the context of remodeled stroma and associated ECM. Data represent at
least two independent experiments. *p% 0.05 (Mann-Whitney U test).
(E) Histological scoring ofmeningeal fibronectin networks during EAE for dual-treated and control groups. See the Supplemental Experimental Procedures for the
scoring system.
(legend continued on next page)
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immunoreactivity within TLTs were unperturbed in LTbR-Ig-
treated mice with Th17 cell A/T EAE (Figures S6B and S6C). To
confirm that inflammation-induced remodeling of the meningeal
stromal cell network in the brain meninges of mice with EAE was
LT independent, we induced Th17 cell A/T EAE in Ltbr/ mice.
Indeed, stromal cell remodeling (as evidenced by an extensive
fibronectin+PDGFRb+ network), accumulation of CD45 gp38+
CD31 FRC-like cells in the brain meninges, and ECM produc-
tion were comparable between wild-type (WT) and Ltbr/
mice with Th17 cell A/T EAE (Figures 4C–4D; Figure S6D).
Therefore, early steps in TLT formation were not affected by
CNS-intrinsic LT-pathway inhibition.
Although the initial remodeling of the meningeal stromal cell
network was intact in EAE mice treated with LTbR-Ig via the
i.c.v. route and the average follicle size was not reduced (Figures
S6E and S6F), TLT-intrinsic B cells appeared more dispersed
(Figure 4E), and meningeal TLTs contained fewer B cells (Fig-
ure 4F; Figure S6F), suggesting that LTbR-derived signals might
be required for subsequent steps in TLT maturation. Moreover,
we found that Th17-cell-induced EAE resulted in the deposition
of complement component C3 within meningeal TLTs, and this
was significantly reduced in mice that had received LTbR-Ig
via the i.c.v. route (Figures 4G–4H; Figure S6F). We observed
an effect of LTbR-Ig on B cell accumulation when EAE was
induced by Th17 cell transfer, but not during active EAE (Figures
S6G and S6H), suggesting that the LT pathway might be more
relevant under Th17-cell-driven conditions. Altogether, the LT
pathway is required not for initial Th17-cell-driven TLT formation
but rather for the recruitment of B cells and the local deposition
of C3 within TLTs.
LTbR is expressed not only on radio-resistant stromal cells but
also on radio-sensitive DCs and macrophages. Because we
observed a significant infiltration of CD11c+ DCs into meningeal
TLTs (Figure 1E), we next determined which LTbR-expressing
cell type was responsible for B cell accumulation within menin-
geal TLTs. To do this, we performed bone marrow chimeras by
using Ltbr/ mice backcrossed onto the SJL/J background to
distinguish between a role for radio-sensitive LTbR+ cells (e.g.,
DCs) and a role for LTbR+ radio-resistant cells (e.g., stroma) in
mediating B cell accumulation in TLTs. Using this approach,
we found that B cell accumulation in TLTs was actually increased
in Ltbr/ / WT SJL/J chimeric mice with Th17 cell A/T EAE
(Figures 4I and 4J). Thus, the accumulation of B cells within
meningeal follicles during Th17 cell A/T EAE is most likely medi-
ated by LTbR signaling in a radio-resistant rather than radio-sen-
sitive cell type.
Although it was clear that an elaborate stromal cell network
had formed in the brain meninges during Th17-cell-driven EAE,
we next determined whether this network could produce the fac-
tors necessary for drawing lymphocytes into emerging TLTs
(chemokines) and providing survival factors for these lympho-
cytes. We therefore performed qRT-PCR on CD45-depleted
meningeal stromal cells from WT and Ltbr/ mice with Th17
cell A/T EAE and their naive counterparts. We found that the che-(F) Clinical scores formice treated with either control Ig or a combination of anti-IL-
independent experiments. **p < 0.001 (two-way ANOVA).
In all cases, center values depicted are means, and variances are ±SE. *p% 0.05,
experiment was day 7 after A/T. See also Figures S4 and S5.
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the B cell survival factor BAFF, were significantly more ex-
pressed in meningeal stromal cells derived from WT and Ltbr/
mice with Th17 cell A/T EAE than in meningeal stroma from naive
mice (Figure 4K). Although Cxcl13 expression was induced in
both WT and Ltbr/ mice, we noted that compared to their
WT counterparts, Ltbr/ mice showed a marked impairment
in the induction ofCxcl13 during EAE (Figure 4K). Thus, although
the initiation of a meningeal stromal cell network is LT indepen-
dent, the optimal maturation of meningeal stromal cells for
recruitment of B cells, induction of Cxcl13, and the deposition
of C3 requires LTbR signaling.
Meningeal Stromal Cells Produce Cytokines that
Polarize and Sustain Th17 Cells
In EAE, the meningeal space represents a principal site for anti-
gen-specific T cell reactivation (Bartholoma¨us et al., 2009).
However, the source of inflammatory mediators shaping intra-
meningeal T cell reactivation remains unclear. To determine
whether meningeal stromal cells are a potential source of cyto-
kines that shape T cell responses in situ, particularly the induc-
tion and maintenance of Th17 cells, we performed qRT-PCR
on CD45-depleted stromal cells isolated from the brain
meninges of mice with EAE. We observed significantly more
expression of the Th17-cell-promoting cytokines Il6, Tgfb, and
Il23 in meningeal stromal cells from mice with Th17 cell A/T
EAE than in naive mice (Figure 5A). Moreover, when cells were
stimulated in vitro with the Th17-cell-derived cytokines IL-17
and IL-22, we likewise observed increased expression of Il6
and Tgfb in cultured meningeal fibroblasts (Figure S4A). We
further examined cytokine expression in Ltbr/ mice with
Th17 cell A/T EAE and observed a significant induction of Il6
and Il23 transcripts but only amodest non-statistically significant
induction of Tgfb in Ltbr/ mice (Figure 5B). Therefore, Th17
cells and/or their by-products activate meningeal stromal cells
to induce expression of cytokines involved in Th17 cell induction
and maintenance.
LTbR Signaling in the Radio-Resistant Compartment Is
Required for Optimal T Cell Responses in the Meninges
Because we observed that meningeal stromal cells induced
expression of pro-inflammatory cytokines both in vitro and in vivo
and that the LT pathway was required for optimal induced
expression of Tgfb, a vital factor for Th17 cell differentiation
(Veldhoen et al., 2006), we hypothesized that LTbR-dependent
signals might influence meningeal CD4+ T cell responses in the
CNS. To first examine whether ablation of LTbR signaling in
the host influences the encephalitogenic T cell response, we
transferred WT Th17 cells into either WT or Ltbr/ recipients.
We observed that the frequency of both IL-17+ and IFN-g+
T cells in the brain was lower in Ltbr/ mice than in their WT
counterparts (Figures 5C and 5D), suggesting that LTbR
signaling is required for optimal T cell cytokine production in
the CNS.17 and IL-22 via the i.c.v. route. Data shown are clinical scores pooled from two
**p% 0.01, ***p% 0.001 (Student’s t test). Day of clinical disease onset for this
c.
Figure 4. The Maturation but Not the Establishment of a Stromal Cell Network in the Meninges Is LT Dependent
(A) Representative IF imaging of a meningeal fibronectin-PDGFRb network from acute-phase Th17 cell A/T EAE mice treated with either control Ig or LTbR-Ig via
the i.c.v. route.
(B) Flow cytometric analysis of gp38+CD31 stromal cells from themeninges of Th17 cell A/T EAEmice treated with either control Ig or LTbR-Ig via the i.c.v. route.
Data represent seven to eight EAE mice per group.
(C) Representative IF imaging of a meningeal fibronectin-PDGFRb network at the acute phase of Th17 cell A/T EAE from either WT or LTbR/ mice.
(D) Flow cytometric analysis of gp38+CD31 stromal cells from the meninges of WT or LTbR/ mice with Th17 cell A/T EAE. Data were pooled from two ex-
periments and represent three independent experiments with three to six EAE mice per group.
(E) Representative IF imaging of B and T lymphocytes in meningeal TLTs from acute-phase Th17 cell A/T EAEmice treated with either control Ig or LTbR-Ig via the
i.c.v. route.
(F) Quantification of the average area of B220+ cells within a TLT on a per-TLT basis in control or LTbR-Ig-treated Th17 cell A/T EAE mice.
(G) Representative IF imaging of C3 deposition and CD45+ cells in meningeal TLT from acute-phase Th17 cell A/T EAEmice treated with either control Ig or LTbR-
Ig via the i.c.v. route.
(H) Quantification of the average area of C3 deposition within a TLT on a per-TLT basis in control or LTbR-Ig-treated Th17 cell A/T EAE mice.
(I) Representative IF of B and T lymphocytes in a meningeal TLT from the acute phase of Th17 cell A/T EAE in either WT/ WT or LTbR// WT chimeric
SJL/J mice.
(legend continued on next page)
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Figure 5. Meningeal Stromal Cells Produce Th17-Cell-Promoting Cytokines, and LTbR Signaling via the Radio-Resistant Compartment Is
Required for Optimal Generation of Pro-inflammatory T Cell Responses in the CNS
(A and B) qRT-PCR analysis of the expression of inflammatory mediators from CD45-depleted meningeal stromal cells isolated from WT (A) or Ltbr/ (B) SJL/J
mice with Th17 cell A/T EAE. Induction of each cytokine was normalized to the baseline expression in naive mice from each respective genotype.
(C and D) Representative FACS plots (C) and flow cytometric analysis (D) of cytokine-producing CD4+ T cells isolated from the brain of WT or Ltbr/mice with
Th17 cell A/T EAE.
(E and F) Representative FACS plots (E) and flow cytometric analysis (F) of IL-17- and IFN-g-producing CD4+ T cells isolated from the brain of WT/ WT or
Ltbr// WT chimeric mice with Th17 cell A/T EAE.
In all cases, data represent two individual experiments with three to six mice per group. Center values depicted are means. *p% 0.05, **p% 0.01 (Mann-Whitney
U test). In all cases, assessments were made on the day following the peak of clinical disease.Next, we induced Th17 cell A/T EAE in WT and Ltbr/ SJL/J
bone marrow chimeras to determine whether LTbR signaling in
the radio-sensitive compartment is required for optimal pro-
inflammatory T cell responses. We observed comparable fre-
quencies of IL-17+ and IFN-g+ T cells in the brain of both(J) Quantification of the average area of B220+ cells within a TLT on a per-follicle ba
A/T EAE.
(K) qRT-PCR analysis of the expression of inflammatorymediators fromCD45-dep
cell A/T EAE. Induction of each chemokine was normalized to the baseline expre
Unless otherwise noted, data represent two individual experiments with three to
(inset images are 8003 magnification). In all cases, center values depicted ar
experiments depicted in (A)–(J), the day of clinical onset was between days 6 a
assessments were made on the day following the peak of clinical disease. See a
1168 Immunity 43, 1160–1173, December 15, 2015 ª2015 Elsevier InWT/WTand Ltbr//WT chimeras (Figures 5E and 5F), sug-
gesting that LTbR signaling in the radio-sensitive compartment
does not significantly influence local T cell cytokine production
in the inflamed CNS. Therefore, whereas LTbR signaling in pe-
ripheral DCs is important for ex vivo T cell recall responsessis inWT/WT or LTbR//WT chimeric SJL/J mice subjected to Th17 cell
letedmeningeal stromal cells isolated fromWT or Ltbr/SJL/Jmicewith Th17
ssion in naive mice from each respective genotype.
six mice per group, and all representative IF images are at 2003magnification
e means. *p % 0.05, **p % 0.01, ****p % 0.0001 (Mann-Whitney U test). In
nd 8 after A/T. Data in (K) represent three pooled experiments; in all cases,
lso Figure S6.
c.
Figure 6. LTab Expression on Transferred Encephalitogenic Th17 Cells Determines De Novo IL-17 Production by Endogenous T Cells
(A) Representative contour plots of transferred CD4+ T cells producing IL-17 and IFN-g (left panel) or endogenous CD4+ T cells producing IL-17 and IFN-g (right
panel) on days 7 and 9 after A/T.
(B) Quantification of the frequency of cytokine-producing adoptively transferred or endogenous CD4+ T cells. Data represent four to seven mice per group per
time point.
In all cases, center values depicted are means. *p% 0.05, **p % 0.01 (Mann-Whitney U test). The day of clinical disease onset was day 7 after A/T. See also
Figure S7 and Table S2.(Summers deLuca and Gommerman, 2012), in the brain it ap-
pears that LTbR signaling in radio-resistant stromal cells is
more important for CNS-intrinsic T cell responses.
Expression of LTab on Th17 Cells Is Required for
De Novo T Cell Responses in the CNS and Robust
Clinical Disease
During relapses, new waves of activated T cells, particularly
Th17 cells, are critically required for propagating disease.
Consistent with the literature (Chiang et al., 2009), we detected
LTab on the surface of Th17 cells derived from the CNS of EAE
mice (Figure S7A). Given that Th17 cells can induce TLTs, we hy-
pothesized that expression of LTab, specifically on Th17 cells,
could be important for propagating subsequent Th17 cell re-
sponses within the CNS. We therefore tested whether deletion
of Ltb only on encephalitogenic Th17 cells would have an impact
on subsequent generation of de novo Th17 cell responses. To do
this, we generated Ltb// Ltb+/ or WT/ Ltb+/ SJL/J LN-
sufficient chimeras as a source of donor cells for Th17 cell A/T
EAE. We found that compared to WT Th17 cell transfer, transfer
of primed Ltb/ Th17 cells failed to induce EAE in recipient mice
(Table S2). To overcome this defect in EAE induction, we modi-
fied our immunization protocol by utilizing a specific lot of myco-Immbacterium that induced a more-robust disease (‘‘potent myco’’)
and accordingly immunized Ltb/ / Ltb+/ or WT / Ltb+/
mice as donors for A/T EAE. In the ‘‘potent myco’’ case, we
found that mice receiving either WT or Ltb/ T cells now ex-
hibited similar clinical symptoms and incidence of EAE (Table
S2). Whereas transferred WT and Ltb/ T cells extracted from
the CNS produced similar amounts of IL-17, the ability of endog-
enous T cells to produce IL-17 at both the clinical onset of dis-
ease (day 7) and the peak of disease (day 9) was abrogated
whenwe used Ltb/ T cells to initiate disease, although produc-
tion of IFN-g by endogenous T cells was normal (Figure 6). These
findings suggest that disease-initiating T cells require Ltb
expression to facilitate the expression of IL-17 in endogenous
cells infiltrating the CNS. Moreover, under milder EAE condi-
tions, Ltb expression is required for propagating disease, remi-
niscent of previous findings whereby EAE relapses that followed
amild acute phasewere inhibited by systemic LTbR-Ig treatment
(Gommerman et al., 2003).
Activated T Cells from MS Patients Express Elevated
Levels of LTbR Ligands
Having demonstrated that adoptively transferred Th17 cells
require Ltb expression to propagate inflammation and disease,unity 43, 1160–1173, December 15, 2015 ª2015 Elsevier Inc. 1169
Figure 7. Elevated Expression of LTbR Li-
gands on Activated Peripheral CD4+ T Cells
from MS Patients
(A) Representative flow cytometric plots of CD4+
T cells purified from peripheral-blood leukocytes,
stimulated with PMA, and then stained with
LTbR-Ig. Representative unstimulated samples
are also shown (left column). Quadrants were set
on the basis of the level of fluorescence derived
from the same antibody panel minus the LTbR-Ig
primary step (but including the secondary anti-
body).
(B and C) The level of LTab-LIGHT on PMA-acti-
vated CD4+ T cells was quantified in terms of MFI
or as a frequency of CD4+ T cells expressing
LTab-LIGHT.
(D) Representative flow cytometric plots demon-
strate the populations of central and effector
memory T cells from healthy control individuals
(left) and MS patients (right). Quadrants were set
on the basis of fluorescence minus one (FMO)
controls.
(E) Flow cytometric analysis of the level of LTab-
LIGHT on central and effector memory T cells in
healthy control individuals and MS patients.
Data were pooled from five separate experiments.
In all cases, center values depicted are means,
and variances are ±SE. *p% 0.05 (Mann-Whitney
U test). See also Figure S7 and Table S3.we determined whether increased surface expression of LTab
would be a hallmark of activated CD4+ T cells derived from MS
patients. We therefore obtained peripheral-blood mononuclear
cells (PBMCs) from MS patients and healthy control individuals
(Table S3) and purified CD4+ T cells. Using LTbR-Ig to detect
LTab-LIGHT, we found that the expression of LTbR ligands
was upregulated on CD69+ T cells activated with phorbol myris-
tate acetate (PMA) (Figure S7B; Figure 7A). Both the surface
expression of LTab-LIGHT (MFI) and the frequency of LTab-
LIGHT-positive cells were modestly higher in MS samples than
in healthy control samples (Figures 7B and 7C). However, there
was no difference in the expression of LTbR ligands between un-
stimulated CD4+ T cells (data not shown) and central and effector
memory T cells (Figures 7D and 7E), suggesting that the elevated
expression of LTbR ligands in MS samples can probably be
attributed to enhanced proximal activation of naive T cells.
DISCUSSION
In this study, we showed that TLTs in the brain meninges are
associated with subpial demyelination, astrogliosis, and com-
plement deposition. Moreover, we showed that the stromal cells
underpinning TLTs not only provide a scaffold that attracts and
supports infiltrating leukocytes but, via coordinated interactions
between Th17 cells and the LT pathway, also produce cytokines
that promote local Th17 cell responses. Administration of block-
ing antibodies to IL-17 and IL-22 via the i.c.v. route reduced the
formation of the FRC network in the meninges, correlating with a
modest reduction in clinical disease. Although this correlation
could have been due to an effect of these cytokines on other
CNS-intrinsic processes, our results demonstrate that it might
also have been due to an impact on meningeal TLT, suggesting1170 Immunity 43, 1160–1173, December 15, 2015 ª2015 Elsevier Inthat early fibroblast remodeling in the meninges might set the
stage for CNS-intrinsic inflammation. Our work provides new in-
sights into a putative role for IL-17, IL-22, and LT in perpetuating
meningeal inflammation during the early stages of EAE.
The finding that meningeal immune cell aggregates were
associated with subpial abnormalities suggests that the
meninges had the capacity to foster pathogenic immune re-
sponses. We hypothesized that TLTs contain stromal cells that
share similarities with lymphoid tissue stroma in order to support
such immune responses. Indeed, emerging evidence suggests
that tissue-resident cells mature to lymphoid-tissue-like stroma
after inflammatory stimuli (Krautler et al., 2012). To date, almost
nothing is known about stromal cell populations in the CNS. Peri-
cytes, vascular smooth muscle cells, and meningeal fibroblasts
are known to reside in the CNS, and more recently the presence
of meningeal lymphatics has been described in the brain (Lou-
veau et al., 2015). Intriguingly, the morphology and surface
markers of meningeal stromal cells that we identified in the brain
meninges of mice with Th17 cell A/T EAE resemble those of
lymphoid FRCs in inflamed LNs (Chai et al., 2013). In addition,
elevated amounts of Tnfsf13b transcript were detected in
CD45 meningeal stromal cells during EAE, consistent with the
observation that BAFF can be produced by LN FRCs (Cremasco
et al., 2014). PDGFRab+ (putative pericytes) within meningeal
stromal cell networks were also observed, and these might
represent FDC precursors whose maturation is also LT depen-
dent (Krautler et al., 2012). However, we were unable to detect
CD35+ or FDC-M1+ FDCs within meningeal TLTs in SJL/J mice
(data not shown), but we note that it might be too early to detect
mature FDCs during the acute phase of Th17-cell-induced EAE.
Both IL-17-producing cells and the LT pathway have indepen-
dently been implicated in TLT formation (Grogan and Ouyang,c.
2012). However, the sequence of signals that culminate
to generate fully mature TLTs is not known, and indeed, in
contrast to the requirements for TLTs found at sites of autoim-
mune-driven tissue pathology, the molecular requirements
for infection-induced TLTs vary depending on the pathogen
(Fleige et al., 2014). Our study now demonstrates concomitant
IL-17- and IL-22-induced stromal cell differentiation and LT-
dependent stromal cell maturation in the context of the inflamed
meninges.
The elaborated ECM-stromal-cell network induced by Th17
cell A/T is not a mere structural scaffold. Rather, our data
demonstrate that Th17-cell-derived and LTbR-dependent sig-
nals cooperate to induce the expression of adhesion molecules,
cytokines, and chemokines that most likely potentiate the ability
of the ECM-stromal-cell network to recruit, retain, and activate
lymphocytes within the meninges. We found that, in addition to
inducing expression of ECM components and stromal cell re-
modeling, adding IL-17 and IL-22 to meningeal fibroblasts also
induced the expression of cytokines Il6 and Tgf, as well as the
Th17-cell-responsive chemokine Cxcl1, but not homeostatic
lymphoid chemokine Cxcl13, Ccl19, or Ccl21. Instead, expres-
sion of Cxcl13 by meningeal stromal cells in the inflamed CNS
was dependent on LTbR signaling in the radio-resistant cell
compartment, although the molecular signals that drive Ccl19
and Ccl21 expression in vivo remain unclear. Tgfb expression
was also sensitive to LTbR signaling, suggesting redundancy
or positive amplification of Tgfb expression between the Th17-
cell-LT axes. Moreover, we found that B cell accumulation within
meningeal TLTs in response to Th17 cell A/T EAE required LTbR
signaling in the radio-resistant compartment. Although our
studies were necessarily confined to the early stages of TLT for-
mation during EAE (because of limitations in i.c.v. pump capac-
ity), it would be interesting to determine whether the reduction of
B cells within TLTs in mice where local LTbR signaling is blocked
has an impact on later stages of disease given that B cells can
play both pro- and anti-inflammatory roles in EAE (Matsushita
et al., 2008). Moreover, with prolonged inflammation, TLTs might
foster a niche for regulatory cells, as has been demonstrated in
the aorta of aged athlerosclerotic mice (Hu et al., 2015).
Compared to mice treated with LTbR-Ig, mice in which LTbR
was deleted on radio-sensitive cells seemed to show the oppo-
site effect, which was an enhanced accumulation of B cells
within TLTs. The reason(s) for this phenomenon are unclear,
but we noted a substantial number of CD11c+ cells within
TLTs. We speculate that because some DCs require LTbR for
their homeostatic maintenance and function (Kabashima et al.,
2005), perhaps local DC populations influence B cell accumula-
tion within TLTs in a LT-dependent manner. Inhibition of LTbR in
the radio-resistant stromal cell compartment presumably over-
rides such a putative DC-driven effect.
In addition to observing effects on B cell accumulation, we
noted that CNS-intrinsic T cell responses were blunted in Ltbr/
mice but normal in Ltbr//WT chimeric mice, suggesting that
the expression of LTbR on radio-resistant cells was required for
promoting T cell responses within the brain meninges. Despite
diminished T cell responses in the meninges of Ltbr/ mice,
these mice did not exhibit impaired induction of EAE, at least
at this early time point (data not shown). It is difficult to interpret
what might be affecting disease susceptibility in Ltbr/ miceImmgiven that transferring Th17 cells into LN-deficient Ltbr/ ani-
mals might have altered leukocyte trafficking into the CNS, in
comparison to CNS-directed trafficking in LN-sufficient animals.
Indeed, LN-deficient C57Bl/6 mice also develop EAE (Greter
et al., 2009).
To circumvent these confounding issues, we performed an
experiment where Ltb/ Th17 cells were generated in a LN-suf-
ficient mouse and subsequently transferred into a WT SJL/J
recipient. Using this approach, we found that Ltb expression
by disease-transferring T cells was critical for IL-17 production
by subsequent waves of endogenous T cells migrating into the
CNS. The impaired ability to perpetuate endogenous Th17 cell
responses occurred despite adequate priming and IL-17 pro-
duction by donor Ltb/ T cells in the recipient mice. However,
we cannot rule out the possibility that this phenotype is due to
a combination of the absence of LTbR signaling in meningeal
stromal cells in the recipient mice and other unmeasured or un-
known intrinsic defects that the transferred Ltb/ T cells ac-
quired during priming in the donor animal.
Meningeal TLTs have been mainly documented in progressive
MS, although they have also been demonstrated in acute MS bi-
opsies (Lucchinetti et al., 2011). Here, using the Th17 cell A/T
model to induce EAE in SJL/J mice, we demonstrated that at
the earliest stages of CNS autoimmunity, meningeal TLTs are
associated with subpial demyelination and gliosis, as well as
complement C3 deposition, which is likewise associated with
CNS pathology (Mead et al., 2004). We postulate that in early
MS, the subpial parenchyma is somewhat protected by the glial
limitans, which inhibits many cells, particularly meningeal-resi-
dent T cells, from entering the parenchyma, although many
T cells do enter around the penetrating vessels. However, over
time, soluble factors emanating from the meninges might cause
a more indolent process of demyelination, astrocytosis, and
axonal degeneration. We speculate that LTab+ Th17 cells circu-
lating in the CSF might begin to remodel meningeal stroma
during the early stages of MS to facilitate such indolent patho-
genesis, and interestingly, both Ltbr and its signaling adaptor
Traf3 have been recently identified as susceptibility loci in MS
(Beecham et al., 2013). Early attenuation of the signals that drive
TLT formation might therefore affect pathogenic processes
emanating from the meninges in the context of MS.
EXPERIMENTAL PROCEDURES
Additional detailed methods can be found in the Supplemental Experimental
Procedures.
Mice
Unless specified otherwise, WT SJL mice were obtained from Harlan Sprague
Dawley. WT CD45.2, LTbR/ CD45.2, LTb/ CD45.2, and LTb/ CD45.1
SJL/J mice were derived from LTbR/, LTb/, or WT C57Bl/6 mice via
speed congenics and backcrossed onto WT SJL/J mice (from Harlan). In
all experiments, 6- to 10-week-old age-matched female mice were used
for comparative studies. For bone marrow chimeras, 2 3 106 bone marrow
cells were transferred intravenously into lethally irradiated (2 3 425 rads)
recipients.
Induction and Clinical Evaluation of EAE
For active EAE, mice were immunized with 100 mg PLP139–151
(HSLGKWLGHPDKF) in an emulsion of complete Freund’s adjuvant in a total
volume of 300 ml administered as three 100 ml subcutaneous injections onunity 43, 1160–1173, December 15, 2015 ª2015 Elsevier Inc. 1171
the back. For A/T EAE, SJL/J donor mice were immunized as described, and
on day 9 after immunization, cells from the spleen and draining LNs (inguinal,
cervical, and brachial) were harvested, restimulated ex vivo, and transferred
into recipient mice. Clinical assessment of mice was performed daily accord-
ing to a modified 16-point scale after EAE induction.
IF and Histological Assessment of TLTs
In all cases, histological analysis was performed on fresh-frozen brain tissue
embedded in optimum cutting temperature (OCT) medium. The tissue was
cryo-sectioned (7–8 mm) and mounted onto positively charged slides (VWR).
The primary antibodies used for IF were as follows: CD4 (RM4-5), B220
(RA3-6B2), CD11c (N418), CD45.1 (A20), CD45.2 (104) TCRb (H57-597),
PDGFRa (APA5), and PDGFRb (APB5), all of which are from eBioscience;
fibronectin (GW20021F, Sigma); smooth muscle actin (1A4, Sigma), and
ERTR7 (T-2109, BMA Biomedical).
Flow Cytometry
Lymphocyte isolation fromCNS tissue was performed as described previously
(deLuca et al., 2010). To track CNS-infiltrating lymphocytes and transferred
lymphocytes in the spleen and cervical LNs, we stained cells with CD4,
CD45.1, and CD45.2 (all from eBioscience) in PBS and 2% FBS with 1 mg/
ml Fc-block.
Isolation of Meninges for FACS and qPCR
Meninges were isolated from mice immediately after sacrifice. Brains were
carefully removed from the skull and placed in a solution of Hank’s balanced
salt solution on ice. Any meninges adhering to the skull were removed and
collected into a solution of 0.5 ml RPMI-1640 on ice. Meninges were carefully
pulled away from the brain tissue so that parenchymal tissue was not collected
and were subjected to further ex vivo or in vitro analysis.
Analysis of Human Peripheral-Blood T Cells
To detect LTab-LIGHT expression on peripheral-blood CD4+ T cells, we first
isolated peripheral-blood leukocytes from RRMS patients (n = 34, average
age = 32 years) and healthy control individuals (n = 20, average age = 40 years).
No correlation between LTab-LIGHT expression and age was observed (data
not shown). Ages were not recorded for 5 of the 20 healthy donors. After stim-
ulation, CD4+ T cells were blocked with 5% rabbit serum (Jackson Immuno-
chemicals) and subsequently stained with LTbR-Ig, followed by anti-human
IgG-PE. All human experiments were pre-approved by the ethics committees
of St. Michael’s Hospital and the University of Toronto, and experiments were
performed in compliance with these approved protocols. Informed consent
was obtained from all subjects.
Data Analysis and Statistics
All statistical tests were analyzed in Prism software (GraphPad). Unless indi-
cated otherwise, the Mann-Whitney U test was performed for IF and flow cy-
tometric analyses comparing two groups.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables, and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.11.010.
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